An in-depth investigation of the mechanism of interaction of the IL13 conjugated nanoliposomes with glioma tumors expressing IL13Rα2 and their ability to overcome the known drug resistance properties was described in our earlier study [23]. The gene discussed is IL13; the disease is central nervous system cancer.